# Elite Value Audit — INV_V3_006

**Device class:** 006
**Tier:** **REJECT**
**Criteria met:** 10/12
**Fatal attacks:** 0
**Timestamp:** 2026-08-16T03:38:30.309404+00:00

## Inventive Nucleus
Replacing the multifilar coaxial lead design with a polymer-jacketed, single-filar, high-strength alloy conductor reduces the risk of lead fracture.

## Claim
```
A method for reducing the risk of lead fracture in an implantable defibrillator, comprising: A) a polymer-jacketed, single-filar, high-strength alloy conductor; and B) a design that minimizes mechanical interaction between the lead and the surrounding tissue.
```

## Economic Value Assessment
- **Customer problem:** Implantable defibrillator leads are prone to fracture, which can lead to device failure and require risky revision surgeries.
- **Economic pain:** Lead fractures result in additional medical procedures, extended hospital stays, increased healthcare costs, and potential patient harm requiring emergency interventions.
- **Current cost:** Average cost of lead revision surgery ranges from $15,000 to $50,000 per procedure (EVIDENCE|INFERENCE)
- **Value created:** Reduces the risk of lead fracture, potentially eliminating costly revision surgeries and improving patient outcomes.
- **Who pays:** Healthcare systems, insurance companies, and patients (through insurance premiums or out-of-pocket costs).
- **Why they pay:** To avoid the significantly higher costs associated with treating lead fractures and performing revision surgeries, while improving patient outcomes and reducing liability.
- **Adoption barrier:** Established manufacturers may resist changing proven designs; regulatory approval requirements for new lead designs; potential concerns about long-term performance of the new material.
- **Value creation types:** COST_REDUCTION, QUALITY_OF_LIFE_IMPROVEMENT, DEVICE_RELIABILITY_ENHANCEMENT
- **Market size evidence:** INFERENCE
- **Market size basis:** Based on the global implantable cardioverter-defibrillator (ICD) market size of approximately $8-10 billion annually, with leads representing a significant portion of this market (estimated 15-25% of total system cost).

## Elite Criteria Scores (12)
| # | Criteria | Met | Confidence | Reasoning |
|---|---|---|---|---|
| 1 | A_large_expensive_problem | ✓ | EVIDENCE | Lead fractures in implantable defibrillators require revision surgeries costing $15,000-$50,000 per  |
| 2 | B_clear_economic_buyer | ✓ | EVIDENCE | Healthcare systems, insurance companies, and patients (through premiums or out-of-pocket costs) all  |
| 3 | C_substantial_measurable_benefit | ✓ | INFERENCE | Reducing lead fractures would decrease revision surgeries, lowering costs by $15,000-$50,000 per avo |
| 4 | D_technically_meaningful_mechanism | ✓ | INFERENCE | Replacing multifilar coaxial design with a polymer-jacketed, single-filar, high-strength alloy condu |
| 5 | E_difficult_to_reproduce_without_the_invention | ✗ | INFERENCE | This appears to be a material substitution and design modification rather than a novel mechanism. Co |
| 6 | F_meaningful_structural_functional_relationship | ✓ | INFERENCE | The single-filar design with high-strength alloy and polymer jacketing creates a meaningful relation |
| 7 | G_plausible_manufacturing_path | ✓ | INFERENCE | Manufacturing a polymer-jacketed, single-filar conductor using existing medical device manufacturing |
| 8 | H_manageable_regulatory_pathway | ✓ | INFERENCE | As a modification to existing lead design rather than a novel device type, this would likely follow  |
| 9 | I_credible_validation_experiment | ✓ | INFERENCE | In vitro mechanical testing (fatigue testing, bending tests) and in vivo animal studies comparing fr |
| 10 | J_credible_patent_claim_space | ✓ | INFERENCE | Claims could be directed to the specific conductor design, the polymer jacket material, the manufact |
| 11 | K_meaningful_difficulty_of_design_around | ✗ | INFERENCE | Competitors could likely design around this by using alternative high-strength materials, different  |
| 12 | L_potential_for_platform_product_expansion | ✓ | INFERENCE | This conductor design could potentially be applied to other implantable devices such as pacemakers,  |
| 13 | E_difficult_to_reproduce | ✗ | HYPOTHESIS | Not assessed |
| 14 | K_meaningful_design_around_difficulty | ✗ | HYPOTHESIS | Not assessed |
| 15 | L_platform_product_expansion_potential | ✗ | HYPOTHESIS | Not assessed |

## Rejection Patterns
**Matched:** material_substitution, known_component_substitution
**New technical effect:** NONE

## Four-Attack Destruction Test
| Attack | Strength | Can Survive | Rationale |
|---|---|---|---|
| NOVELTY_102 | NONE | ✓ | None of the provided prior-art references disclose information about implantable defibrillators, lea |
| OBVIOUSNESS_103 | NONE | ✓ | None of the provided prior-art references contain information about implantable defibrillators, lead |
| ENABLEMENT_112 | NONE | ✓ | The enablement analysis requires understanding the specific details of the polymer-jacketed, single- |
| DESIGN_AROUND | MODERATE | ✓ | A competitor could design a multifilar lead with enhanced flexibility at critical stress points usin |

## Prior-Art Search Provenance
- **Sources searched:** GOOGLE_PATENTS, PATSNAP_EUREKA, LENS_SCHOLARLY
- **Sources live:** GOOGLE_PATENTS, LENS_SCHOLARLY
- **Total hits:** 6
- **Patent family normalization:** Applied (US/WO/EP/CN/JP/KR/AU collapsed)

## Tier Reasoning
Rejection patterns matched (['material_substitution', 'known_component_substitution']) with no new technical effect

## Honest Disclosure
- LLM calls: 4
- Elapsed: 32.8s
- All economic numbers tagged: EVIDENCE | INFERENCE | HYPOTHESIS
- Human patent lawyer review remains a separate final act
- This audit may output STRONG_CANDIDATE_FOR_FILING but NEVER LEGALLY_PATENTABLE